| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.41e-09 | 16 | 23 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 7.90e-09 | 21 | 23 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 3.93e-08 | 85 | 23 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 8.32e-05 | 12 | 23 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 1.92e-04 | 18 | 23 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.13e-04 | 102 | 23 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 4.38e-04 | 27 | 23 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | laminin binding | 6.96e-04 | 34 | 23 | 2 | GO:0043236 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 7.38e-04 | 35 | 23 | 2 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 7.38e-04 | 35 | 23 | 2 | GO:0071814 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 9.16e-04 | 39 | 23 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | clathrin binding | 2.37e-03 | 63 | 23 | 2 | GO:0030276 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.17e-03 | 73 | 23 | 2 | GO:0050840 | |
| GeneOntologyMolecularFunction | methylated histone binding | 4.37e-03 | 86 | 23 | 2 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 4.57e-03 | 88 | 23 | 2 | GO:0140034 | |
| GeneOntologyMolecularFunction | amide binding | 4.71e-03 | 299 | 23 | 3 | GO:0033218 | |
| GeneOntologyMolecularFunction | peptide binding | 5.60e-03 | 318 | 23 | 3 | GO:0042277 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 9.30e-03 | 127 | 23 | 2 | GO:0008094 | |
| GeneOntologyMolecularFunction | calcium ion binding | 9.85e-03 | 749 | 23 | 4 | GO:0005509 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.21e-08 | 5 | 23 | 3 | GO:1905167 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 4.23e-08 | 7 | 23 | 3 | GO:1904352 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 2.23e-07 | 625 | 23 | 8 | GO:0051960 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 2.65e-07 | 12 | 23 | 3 | GO:1905165 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 4.37e-07 | 14 | 23 | 3 | GO:1904350 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.01e-06 | 515 | 23 | 7 | GO:0050767 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 2.41e-06 | 24 | 23 | 3 | GO:1905146 | |
| GeneOntologyBiologicalProcess | protein catabolic process in the vacuole | 3.90e-06 | 28 | 23 | 3 | GO:0007039 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process | 4.52e-06 | 228 | 23 | 5 | GO:0045732 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 1.16e-05 | 40 | 23 | 3 | GO:0097242 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 1.19e-05 | 5 | 23 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | regulation of gliogenesis | 2.19e-05 | 151 | 23 | 4 | GO:0014013 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 3.32e-05 | 8 | 23 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process | 7.33e-05 | 407 | 23 | 5 | GO:0042176 | |
| GeneOntologyBiologicalProcess | gliogenesis | 1.00e-04 | 435 | 23 | 5 | GO:0042063 | |
| GeneOntologyBiologicalProcess | regulation of triglyceride catabolic process | 1.24e-04 | 15 | 23 | 2 | GO:0010896 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 1.35e-04 | 1095 | 23 | 7 | GO:0060284 | |
| GeneOntologyBiologicalProcess | cholesterol import | 1.41e-04 | 16 | 23 | 2 | GO:0070508 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.43e-04 | 92 | 23 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | regulation of glial cell differentiation | 2.05e-04 | 104 | 23 | 3 | GO:0045685 | |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 2.11e-04 | 105 | 23 | 3 | GO:0048708 | |
| GeneOntologyBiologicalProcess | negative regulation of astrocyte differentiation | 2.71e-04 | 22 | 23 | 2 | GO:0048712 | |
| GeneOntologyBiologicalProcess | transcytosis | 3.23e-04 | 24 | 23 | 2 | GO:0045056 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 4.04e-04 | 321 | 23 | 4 | GO:0010001 | |
| GeneOntologyBiologicalProcess | artery development | 4.22e-04 | 133 | 23 | 3 | GO:0060840 | |
| GeneOntologyBiologicalProcess | lipoprotein transport | 4.42e-04 | 28 | 23 | 2 | GO:0042953 | |
| GeneOntologyBiologicalProcess | lipoprotein localization | 4.74e-04 | 29 | 23 | 2 | GO:0044872 | |
| GeneOntologyBiologicalProcess | astrocyte activation | 4.74e-04 | 29 | 23 | 2 | GO:0048143 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 4.85e-04 | 337 | 23 | 4 | GO:0006898 | |
| GeneOntologyBiologicalProcess | triglyceride catabolic process | 5.08e-04 | 30 | 23 | 2 | GO:0019433 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 5.83e-04 | 354 | 23 | 4 | GO:0050769 | |
| GeneOntologyBiologicalProcess | glial cell development | 6.85e-04 | 157 | 23 | 3 | GO:0021782 | |
| GeneOntologyBiologicalProcess | negative regulation of glial cell differentiation | 8.60e-04 | 39 | 23 | 2 | GO:0045686 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | 8.79e-04 | 1488 | 23 | 7 | GO:0051241 | |
| GeneOntologyBiologicalProcess | positive regulation of catabolic process | 9.04e-04 | 701 | 23 | 5 | GO:0009896 | |
| GeneOntologyBiologicalProcess | negative regulation of neurogenesis | 9.08e-04 | 173 | 23 | 3 | GO:0050768 | |
| GeneOntologyBiologicalProcess | neutral lipid catabolic process | 9.50e-04 | 41 | 23 | 2 | GO:0046461 | |
| GeneOntologyBiologicalProcess | acylglycerol catabolic process | 9.50e-04 | 41 | 23 | 2 | GO:0046464 | |
| GeneOntologyBiologicalProcess | negative regulation of protein metabolic process | 9.88e-04 | 1088 | 23 | 6 | GO:0051248 | |
| GeneOntologyBiologicalProcess | regulation of astrocyte differentiation | 1.04e-03 | 43 | 23 | 2 | GO:0048710 | |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 1.08e-03 | 184 | 23 | 3 | GO:0051961 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 1.08e-03 | 418 | 23 | 4 | GO:0051962 | |
| GeneOntologyBiologicalProcess | protein catabolic process | 1.12e-03 | 1115 | 23 | 6 | GO:0030163 | |
| GeneOntologyBiologicalProcess | astrocyte development | 1.25e-03 | 47 | 23 | 2 | GO:0014002 | |
| GeneOntologyBiologicalProcess | central nervous system development | 1.62e-03 | 1197 | 23 | 6 | GO:0007417 | |
| GeneOntologyBiologicalProcess | positive regulation of axon extension | 1.70e-03 | 55 | 23 | 2 | GO:0045773 | |
| GeneOntologyBiologicalProcess | receptor recycling | 1.70e-03 | 55 | 23 | 2 | GO:0001881 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.76e-03 | 218 | 23 | 3 | GO:0090101 | |
| GeneOntologyBiologicalProcess | endocytosis | 1.89e-03 | 827 | 23 | 5 | GO:0006897 | |
| GeneOntologyBiologicalProcess | regulation of triglyceride metabolic process | 1.89e-03 | 58 | 23 | 2 | GO:0090207 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 2.02e-03 | 60 | 23 | 2 | GO:0045005 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | 2.04e-03 | 1252 | 23 | 6 | GO:0009894 | |
| GeneOntologyBiologicalProcess | negative regulation of gliogenesis | 2.16e-03 | 62 | 23 | 2 | GO:0014014 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | 2.21e-03 | 1272 | 23 | 6 | GO:1901698 | |
| GeneOntologyBiologicalProcess | regulation of myelination | 2.52e-03 | 67 | 23 | 2 | GO:0031641 | |
| GeneOntologyBiologicalProcess | glycerolipid catabolic process | 2.74e-03 | 70 | 23 | 2 | GO:0046503 | |
| GeneOntologyBiologicalProcess | glial cell activation | 2.74e-03 | 70 | 23 | 2 | GO:0061900 | |
| GeneOntologyBiologicalProcess | positive chemotaxis | 3.14e-03 | 75 | 23 | 2 | GO:0050918 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 3.24e-03 | 270 | 23 | 3 | GO:0007160 | |
| GeneOntologyBiologicalProcess | response to nutrient levels | 3.28e-03 | 566 | 23 | 4 | GO:0031667 | |
| GeneOntologyBiologicalProcess | phagocytosis | 3.37e-03 | 274 | 23 | 3 | GO:0006909 | |
| GeneOntologyBiologicalProcess | regulation of lipid catabolic process | 3.39e-03 | 78 | 23 | 2 | GO:0050994 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 3.57e-03 | 80 | 23 | 2 | GO:0030514 | |
| GeneOntologyBiologicalProcess | aorta development | 3.57e-03 | 80 | 23 | 2 | GO:0035904 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokine production | 3.72e-03 | 586 | 23 | 4 | GO:0001819 | |
| GeneOntologyBiologicalProcess | receptor metabolic process | 3.74e-03 | 82 | 23 | 2 | GO:0043112 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | 3.83e-03 | 591 | 23 | 4 | GO:1903829 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 3.83e-03 | 83 | 23 | 2 | GO:0060976 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.40e-05 | 45 | 22 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 7.89e-05 | 80 | 22 | 3 | GO:0005905 | |
| GeneOntologyCellularComponent | cell surface | 9.90e-05 | 1111 | 22 | 7 | GO:0009986 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.72e-04 | 519 | 22 | 5 | GO:0009897 | |
| GeneOntologyCellularComponent | endolysosome membrane | 1.99e-04 | 20 | 22 | 2 | GO:0036020 | |
| GeneOntologyCellularComponent | endolysosome | 4.52e-04 | 30 | 22 | 2 | GO:0036019 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 5.14e-04 | 32 | 22 | 2 | GO:0005721 | |
| GeneOntologyCellularComponent | lysosomal membrane | 1.26e-03 | 462 | 22 | 4 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 1.26e-03 | 462 | 22 | 4 | GO:0098852 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.37e-03 | 212 | 22 | 3 | GO:0030666 | |
| GeneOntologyCellularComponent | vacuolar membrane | 1.77e-03 | 507 | 22 | 4 | GO:0005774 | |
| GeneOntologyCellularComponent | side of membrane | 1.85e-03 | 875 | 22 | 5 | GO:0098552 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 1.89e-03 | 237 | 22 | 3 | GO:0030136 | |
| GeneOntologyCellularComponent | growth cone | 2.08e-03 | 245 | 22 | 3 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.28e-03 | 253 | 22 | 3 | GO:0030427 | |
| GeneOntologyCellularComponent | receptor complex | 2.90e-03 | 581 | 22 | 4 | GO:0043235 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 3.10e-03 | 79 | 22 | 2 | GO:0030669 | |
| GeneOntologyCellularComponent | apical part of cell | 3.10e-03 | 592 | 22 | 4 | GO:0045177 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 5.01e-03 | 101 | 22 | 2 | GO:0045334 | |
| GeneOntologyCellularComponent | heterochromatin | 5.01e-03 | 101 | 22 | 2 | GO:0000792 | |
| GeneOntologyCellularComponent | basal plasma membrane | 5.84e-03 | 354 | 22 | 3 | GO:0009925 | |
| GeneOntologyCellularComponent | coated vesicle | 6.12e-03 | 360 | 22 | 3 | GO:0030135 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 6.13e-03 | 112 | 22 | 2 | GO:0055038 | |
| GeneOntologyCellularComponent | endosome | 6.38e-03 | 1167 | 22 | 5 | GO:0005768 | |
| GeneOntologyCellularComponent | basal part of cell | 7.00e-03 | 378 | 22 | 3 | GO:0045178 | |
| GeneOntologyCellularComponent | endocytic vesicle | 7.31e-03 | 384 | 22 | 3 | GO:0030139 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 7.90e-03 | 1228 | 22 | 5 | GO:0036477 | |
| GeneOntologyCellularComponent | lysosome | 9.42e-03 | 811 | 22 | 4 | GO:0005764 | |
| GeneOntologyCellularComponent | lytic vacuole | 9.42e-03 | 811 | 22 | 4 | GO:0000323 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 1.02e-02 | 1307 | 22 | 5 | GO:0030659 | |
| GeneOntologyCellularComponent | distal axon | 1.03e-02 | 435 | 22 | 3 | GO:0150034 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 1.03e-02 | 147 | 22 | 2 | GO:0030665 | |
| GeneOntologyCellularComponent | vesicle membrane | 1.08e-02 | 1325 | 22 | 5 | GO:0012506 | |
| GeneOntologyCellularComponent | early endosome | 1.35e-02 | 481 | 22 | 3 | GO:0005769 | |
| GeneOntologyCellularComponent | vacuole | 1.41e-02 | 913 | 22 | 4 | GO:0005773 | |
| Domain | - | 7.81e-10 | 39 | 22 | 5 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 8.91e-10 | 40 | 22 | 5 | IPR023415 | |
| Domain | Ldl_recept_b | 1.43e-09 | 14 | 22 | 4 | PF00058 | |
| Domain | LDLRB | 1.43e-09 | 14 | 22 | 4 | PS51120 | |
| Domain | Ldl_recept_a | 1.65e-09 | 45 | 22 | 5 | PF00057 | |
| Domain | - | 1.85e-09 | 46 | 22 | 5 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.85e-09 | 46 | 22 | 5 | IPR011042 | |
| Domain | LY | 1.95e-09 | 15 | 22 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.95e-09 | 15 | 22 | 4 | IPR000033 | |
| Domain | LDLRA_1 | 2.31e-09 | 48 | 22 | 5 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.57e-09 | 49 | 22 | 5 | IPR002172 | |
| Domain | LDLa | 2.57e-09 | 49 | 22 | 5 | SM00192 | |
| Domain | LDLRA_2 | 2.57e-09 | 49 | 22 | 5 | PS50068 | |
| Domain | EGF_3 | 6.68e-06 | 235 | 22 | 5 | PS50026 | |
| Domain | EGF | 6.68e-06 | 235 | 22 | 5 | SM00181 | |
| Domain | EGF-like_dom | 8.85e-06 | 249 | 22 | 5 | IPR000742 | |
| Domain | EGF-like_CS | 1.11e-05 | 261 | 22 | 5 | IPR013032 | |
| Domain | EGF_2 | 1.20e-05 | 265 | 22 | 5 | PS01186 | |
| Domain | EGF_CA | 1.36e-04 | 86 | 22 | 3 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.95e-04 | 97 | 22 | 3 | IPR018097 | |
| Domain | EGF_1 | 2.05e-04 | 255 | 22 | 4 | PS00022 | |
| Domain | EGF_CA | 2.07e-04 | 99 | 22 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.13e-04 | 100 | 22 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.53e-04 | 106 | 22 | 3 | IPR000152 | |
| Domain | EGF_CA | 3.82e-04 | 122 | 22 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.01e-04 | 124 | 22 | 3 | IPR001881 | |
| Domain | cEGF | 4.23e-04 | 26 | 22 | 2 | IPR026823 | |
| Domain | cEGF | 4.23e-04 | 26 | 22 | 2 | PF12662 | |
| Domain | Growth_fac_rcpt_ | 7.83e-04 | 156 | 22 | 3 | IPR009030 | |
| Domain | CUB | 1.76e-03 | 53 | 22 | 2 | PS01180 | |
| Domain | CUB_dom | 2.03e-03 | 57 | 22 | 2 | IPR000859 | |
| Domain | EGF_extracell | 2.25e-03 | 60 | 22 | 2 | IPR013111 | |
| Domain | EGF_2 | 2.25e-03 | 60 | 22 | 2 | PF07974 | |
| Domain | ZF_PHD_2 | 5.53e-03 | 95 | 22 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 5.65e-03 | 96 | 22 | 2 | PS01359 | |
| Domain | EGF | 9.55e-03 | 126 | 22 | 2 | PF00008 | |
| Domain | Znf_FYVE_PHD | 1.28e-02 | 147 | 22 | 2 | IPR011011 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.64e-05 | 48 | 15 | 3 | M27642 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 3.37e-05 | 381 | 15 | 5 | M48063 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 8.19e-05 | 13 | 15 | 2 | M42551 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5 | 1.10e-04 | 15 | 15 | 2 | M42552 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.48e-04 | 100 | 15 | 3 | M27158 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1 | 1.60e-04 | 18 | 15 | 2 | M42559 | |
| Pathway | WP_STATIN_PATHWAY | 1.79e-04 | 19 | 15 | 2 | MM15868 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4 | 2.41e-04 | 22 | 15 | 2 | M42574 | |
| Pathway | WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION | 4.83e-04 | 31 | 15 | 2 | M39514 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.02e-03 | 45 | 15 | 2 | MM15344 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 1.10e-03 | 198 | 15 | 3 | M18311 | |
| Pathway | WP_VITAMIN_B12_METABOLISM | 1.46e-03 | 54 | 15 | 2 | M39337 | |
| Pubmed | 2.52e-09 | 5 | 23 | 3 | 19047013 | ||
| Pubmed | 2.52e-09 | 5 | 23 | 3 | 18685438 | ||
| Pubmed | 5.05e-09 | 6 | 23 | 3 | 9837937 | ||
| Pubmed | 8.83e-09 | 7 | 23 | 3 | 12169628 | ||
| Pubmed | 2.12e-08 | 9 | 23 | 3 | 20005821 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 9.15e-08 | 14 | 23 | 3 | 17389516 | |
| Pubmed | 2.05e-07 | 18 | 23 | 3 | 10827173 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 3.33e-07 | 21 | 23 | 3 | 21337463 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 17505534 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 34445520 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 17889283 | ||
| Pubmed | Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. | 4.18e-07 | 2 | 23 | 2 | 11971949 | |
| Pubmed | LRP: role in vascular wall integrity and protection from atherosclerosis. | 4.18e-07 | 2 | 23 | 2 | 12690199 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 10575007 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 17709443 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 9449704 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 25546260 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 23846497 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 19667105 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 21730304 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 18990694 | ||
| Pubmed | Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse. | 1.25e-06 | 3 | 23 | 2 | 17303763 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 18367731 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 30100244 | ||
| Pubmed | RAGE, LDL receptor, and LRP1 expression in the brains of SAMP8. | 1.25e-06 | 3 | 23 | 2 | 19539695 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 23675525 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 14739216 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 28799085 | ||
| Pubmed | Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report. | 1.25e-06 | 3 | 23 | 2 | 30567480 | |
| Pubmed | LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages. | 1.25e-06 | 3 | 23 | 2 | 26061292 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 1423604 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 19742316 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 27522265 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 22174911 | ||
| Pubmed | Apolipoprotein E isoform-specific effects on lipoprotein receptor processing. | 2.51e-06 | 4 | 23 | 2 | 25015123 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 12413896 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 18566402 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 31108099 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 27365402 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 17038633 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 17080197 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 20030366 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 7775583 | ||
| Pubmed | Developmental regulation of LR11 expression in murine brain. | 2.51e-06 | 4 | 23 | 2 | 9726247 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 11421580 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 15863833 | ||
| Pubmed | Brown adipose tissue activity controls triglyceride clearance. | 2.51e-06 | 4 | 23 | 2 | 21258337 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 20360257 | ||
| Pubmed | LRP1 controls cPLA2 phosphorylation, ABCA1 expression and cellular cholesterol export. | 2.51e-06 | 4 | 23 | 2 | 19718435 | |
| Pubmed | Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice. | 2.51e-06 | 4 | 23 | 2 | 9788969 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 23283348 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 15840700 | ||
| Pubmed | 3.94e-06 | 164 | 23 | 4 | 32409323 | ||
| Pubmed | 4.02e-06 | 47 | 23 | 3 | 11208732 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 17055779 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 8013374 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 16101684 | ||
| Pubmed | Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. | 4.18e-06 | 5 | 23 | 2 | 17326667 | |
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 30700132 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 28604703 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 18635818 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 11100124 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 23011131 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 12746448 | ||
| Pubmed | Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo. | 4.18e-06 | 5 | 23 | 2 | 18992221 | |
| Pubmed | Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. | 4.18e-06 | 5 | 23 | 2 | 23959870 | |
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 22383525 | ||
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 19147818 | ||
| Pubmed | ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors. | 6.26e-06 | 6 | 23 | 2 | 27400128 | |
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 16478678 | ||
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 31023188 | ||
| Pubmed | Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion. | 6.26e-06 | 6 | 23 | 2 | 25954050 | |
| Pubmed | 8.77e-06 | 7 | 23 | 2 | 8798151 | ||
| Pubmed | 8.77e-06 | 7 | 23 | 2 | 7595098 | ||
| Pubmed | Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans. | 8.77e-06 | 7 | 23 | 2 | 23676495 | |
| Pubmed | 1.17e-05 | 8 | 23 | 2 | 10380922 | ||
| Pubmed | 1.40e-05 | 71 | 23 | 3 | 33541421 | ||
| Pubmed | Targeted inactivation of the mouse alpha 2-macroglobulin gene. | 1.50e-05 | 9 | 23 | 2 | 7544347 | |
| Pubmed | LDL receptor-related protein as a component of the midkine receptor. | 1.50e-05 | 9 | 23 | 2 | 10772929 | |
| Pubmed | Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. | 1.50e-05 | 9 | 23 | 2 | 11247302 | |
| Pubmed | 2.29e-05 | 11 | 23 | 2 | 24639464 | ||
| Pubmed | 2.31e-05 | 257 | 23 | 4 | 16335952 | ||
| Pubmed | 3.79e-05 | 14 | 23 | 2 | 15082773 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 4.04e-05 | 101 | 23 | 3 | 23382219 | |
| Pubmed | 4.99e-05 | 16 | 23 | 2 | 26263173 | ||
| Pubmed | Histone H3.3 maintains genome integrity during mammalian development. | 4.99e-05 | 16 | 23 | 2 | 26159997 | |
| Pubmed | 8.72e-05 | 21 | 23 | 2 | 9616220 | ||
| Pubmed | Differential expression and function of ABCG1 and ABCG4 during development and aging. | 9.59e-05 | 22 | 23 | 2 | 19633360 | |
| Pubmed | 1.48e-04 | 1285 | 23 | 6 | 35914814 | ||
| Pubmed | Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. | 1.56e-04 | 28 | 23 | 2 | 24462114 | |
| Pubmed | 1.68e-04 | 29 | 23 | 2 | 20167577 | ||
| Pubmed | 1.92e-04 | 31 | 23 | 2 | 20031551 | ||
| Pubmed | 5.44e-04 | 52 | 23 | 2 | 26590417 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 5.71e-04 | 248 | 23 | 3 | 24006456 | |
| Interaction | ZFP41 interactions | 4.05e-07 | 57 | 22 | 4 | int:ZFP41 | |
| Interaction | EGFL6 interactions | 1.48e-06 | 21 | 22 | 3 | int:EGFL6 | |
| Interaction | NTN5 interactions | 2.25e-06 | 24 | 22 | 3 | int:NTN5 | |
| Interaction | GOLGA8G interactions | 2.25e-06 | 24 | 22 | 3 | int:GOLGA8G | |
| Interaction | DLK2 interactions | 7.88e-06 | 36 | 22 | 3 | int:DLK2 | |
| Interaction | GREM2 interactions | 8.56e-06 | 37 | 22 | 3 | int:GREM2 | |
| Interaction | LDLRAP1 interactions | 8.56e-06 | 37 | 22 | 3 | int:LDLRAP1 | |
| Interaction | APOE interactions | 3.25e-05 | 171 | 22 | 4 | int:APOE | |
| Interaction | ANKRD36B interactions | 3.71e-05 | 60 | 22 | 3 | int:ANKRD36B | |
| Interaction | LRPAP1 interactions | 3.97e-05 | 180 | 22 | 4 | int:LRPAP1 | |
| Interaction | IGFL3 interactions | 7.25e-05 | 75 | 22 | 3 | int:IGFL3 | |
| Interaction | TAFA3 interactions | 8.15e-05 | 78 | 22 | 3 | int:TAFA3 | |
| Interaction | NGF interactions | 8.81e-05 | 13 | 22 | 2 | int:NGF | |
| Interaction | SNX17 interactions | 9.12e-05 | 81 | 22 | 3 | int:SNX17 | |
| Interaction | LRP1B interactions | 1.05e-04 | 85 | 22 | 3 | int:LRP1B | |
| Interaction | CUBN interactions | 1.18e-04 | 15 | 22 | 2 | int:CUBN | |
| Interaction | TIMP3 interactions | 1.25e-04 | 90 | 22 | 3 | int:TIMP3 | |
| Interaction | MDK interactions | 1.29e-04 | 91 | 22 | 3 | int:MDK | |
| Interaction | DEFB123 interactions | 1.35e-04 | 16 | 22 | 2 | int:DEFB123 | |
| Interaction | SCN3A interactions | 1.35e-04 | 16 | 22 | 2 | int:SCN3A | |
| Interaction | CTSG interactions | 1.46e-04 | 95 | 22 | 3 | int:CTSG | |
| Interaction | CCN6 interactions | 1.92e-04 | 19 | 22 | 2 | int:CCN6 | |
| Interaction | DAB1 interactions | 2.08e-04 | 107 | 22 | 3 | int:DAB1 | |
| Interaction | ZNF224 interactions | 2.14e-04 | 20 | 22 | 2 | int:ZNF224 | |
| Interaction | ZDHHC15 interactions | 3.29e-04 | 125 | 22 | 3 | int:ZDHHC15 | |
| Interaction | LGALS1 interactions | 4.18e-04 | 332 | 22 | 4 | int:LGALS1 | |
| Interaction | FEZF1 interactions | 4.23e-04 | 28 | 22 | 2 | int:FEZF1 | |
| Interaction | ZNF517 interactions | 4.54e-04 | 29 | 22 | 2 | int:ZNF517 | |
| Interaction | DAB2 interactions | 4.59e-04 | 140 | 22 | 3 | int:DAB2 | |
| Interaction | ZNF408 interactions | 5.08e-04 | 145 | 22 | 3 | int:ZNF408 | |
| Interaction | ITGB1BP1 interactions | 5.88e-04 | 33 | 22 | 2 | int:ITGB1BP1 | |
| Interaction | ANKS1B interactions | 6.25e-04 | 34 | 22 | 2 | int:ANKS1B | |
| Interaction | LPL interactions | 6.62e-04 | 35 | 22 | 2 | int:LPL | |
| Interaction | SOST interactions | 6.62e-04 | 35 | 22 | 2 | int:SOST | |
| Interaction | VEGFD interactions | 7.81e-04 | 38 | 22 | 2 | int:VEGFD | |
| Interaction | DSCAM interactions | 8.21e-04 | 171 | 22 | 3 | int:DSCAM | |
| Interaction | CCN2 interactions | 8.65e-04 | 40 | 22 | 2 | int:CCN2 | |
| Interaction | TRMT44 interactions | 8.65e-04 | 40 | 22 | 2 | int:TRMT44 | |
| Interaction | ZNF264 interactions | 9.09e-04 | 41 | 22 | 2 | int:ZNF264 | |
| Interaction | SPRR1B interactions | 1.09e-03 | 45 | 22 | 2 | int:SPRR1B | |
| Interaction | CMA1 interactions | 1.14e-03 | 46 | 22 | 2 | int:CMA1 | |
| Interaction | TAFA2 interactions | 1.19e-03 | 47 | 22 | 2 | int:TAFA2 | |
| Interaction | APBA2 interactions | 1.24e-03 | 48 | 22 | 2 | int:APBA2 | |
| Interaction | WNT3A interactions | 1.30e-03 | 49 | 22 | 2 | int:WNT3A | |
| Interaction | DKK2 interactions | 1.30e-03 | 49 | 22 | 2 | int:DKK2 | |
| Interaction | FOXD4L6 interactions | 1.30e-03 | 49 | 22 | 2 | int:FOXD4L6 | |
| Interaction | TYW3 interactions | 1.52e-03 | 53 | 22 | 2 | int:TYW3 | |
| Interaction | SERPINE1 interactions | 1.57e-03 | 54 | 22 | 2 | int:SERPINE1 | |
| Interaction | SMOC1 interactions | 1.57e-03 | 54 | 22 | 2 | int:SMOC1 | |
| GeneFamily | Low density lipoprotein receptors | 1.31e-07 | 13 | 15 | 3 | 634 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-08 | 185 | 23 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-06 | 179 | 23 | 4 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-06 | 183 | 23 | 4 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-06 | 189 | 23 | 4 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-06 | 191 | 23 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.08e-06 | 199 | 23 | 4 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.08e-06 | 199 | 23 | 4 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.14e-06 | 200 | 23 | 4 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.31e-05 | 143 | 23 | 3 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.43e-05 | 144 | 23 | 3 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-05 | 153 | 23 | 3 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.88e-05 | 156 | 23 | 3 | 25b0936960be4955b6a6d6b8a867fdd4be548f05 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.56e-05 | 161 | 23 | 3 | 9f02b94e29e60d50e92eaa748ebf0c36d3671bb3 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-05 | 172 | 23 | 3 | 5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.35e-05 | 173 | 23 | 3 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 9.51e-05 | 174 | 23 | 3 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 179 | 23 | 3 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.07e-04 | 181 | 23 | 3 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 183 | 23 | 3 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-04 | 184 | 23 | 3 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.12e-04 | 184 | 23 | 3 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 185 | 23 | 3 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 185 | 23 | 3 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 185 | 23 | 3 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-04 | 186 | 23 | 3 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-04 | 187 | 23 | 3 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.21e-04 | 189 | 23 | 3 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-04 | 191 | 23 | 3 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 193 | 23 | 3 | 3038ed3e53d3367136fac5c9773cd5b7414f49d3 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 194 | 23 | 3 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.37e-04 | 197 | 23 | 3 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | P03-Mesenchymal-myocytic_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.37e-04 | 197 | 23 | 3 | 079db904a08743b3c555cb7b3f5fb5c978dde25a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 197 | 23 | 3 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-04 | 197 | 23 | 3 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 197 | 23 | 3 | 090a251194da3e2806989d9a522588f83f52da7f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-04 | 197 | 23 | 3 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-04 | 197 | 23 | 3 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.37e-04 | 197 | 23 | 3 | 2cec938caf6ffd031cea37277071487e59b2c71c | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.39e-04 | 198 | 23 | 3 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 1.39e-04 | 198 | 23 | 3 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 1.41e-04 | 199 | 23 | 3 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 1.41e-04 | 199 | 23 | 3 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 23 | 3 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 23 | 3 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 23 | 3 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 23 | 3 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Reln_(Neuron.Gad1Gad2.Cplx3-Reln)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.49e-04 | 61 | 23 | 2 | fec6c9a4e12c260338856567bf547f914f473dbb | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Reln_(Neuron.Gad1Gad2.Cplx3-Reln)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.49e-04 | 61 | 23 | 2 | 06aab3f1743ced1e46d22f0310f1cdb70c7a108e | |
| ToppCell | Control-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.30e-03 | 104 | 23 | 2 | 5f72aa686b0fb83d401621e1b9d9c69e56105570 | |
| ToppCell | Mild/Remission-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.37e-03 | 107 | 23 | 2 | 1ab09acb66e4282688fd1f6782a4009f4ea18c41 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Deptor_(Deep_layer_pyramidal_cells--Layer_5a)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.40e-03 | 108 | 23 | 2 | 514dfc3f7ac303311ae599f981f3f3c7eb6801b8 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.50e-03 | 112 | 23 | 2 | 518b7ab98b988b23f3d0f0e1f4fe90a7068f9d87 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Papillary_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.58e-03 | 115 | 23 | 2 | 5f6f6a0f59f0f68aa20f9d98a15118176281ace6 | |
| ToppCell | Severe-B_naive-13|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.61e-03 | 116 | 23 | 2 | f81a7c3e9cbf39124232d98e2a3a3e308137f391 | |
| ToppCell | Control-B_naive-4|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.61e-03 | 116 | 23 | 2 | 35d471c8dbf408d0be3837c428d9c2a73c805a6f | |
| ToppCell | PND07-28-samps-Lymphocyte-T_cells-T_cells_1|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.66e-03 | 118 | 23 | 2 | 461a971f3e8047c727b7c6e00d2d64e97d50c6de | |
| ToppCell | Severe-B_naive-13|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.72e-03 | 120 | 23 | 2 | d08edc09de8497714af55a6ca08a447cd71095e7 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.92e-03 | 127 | 23 | 2 | 50055d5b781e40737e00fa3244cbf9a7517f14b1 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Acinar_Adenocarcinoma-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.01e-03 | 130 | 23 | 2 | 0219d0d5d21df08f816569c7eb34f1bfa095d29a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-03 | 133 | 23 | 2 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.14e-03 | 134 | 23 | 2 | 0b1bb6fee8a2d8c27bca6d9cac6b47e85073dbf7 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_-_proliferative|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.20e-03 | 136 | 23 | 2 | 96370f0e3abf1c9ec7a91595b5d0f97ac2ab4b78 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.33e-03 | 140 | 23 | 2 | 82b150e9e9962460a5cd6bef7ee04f28f5c05d1a | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 2.36e-03 | 141 | 23 | 2 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-13|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-03 | 144 | 23 | 2 | b2a9f3b5dd46d27689467f4a5fd717cd5827821f | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.63e-03 | 149 | 23 | 2 | efa30fcd9370f98eb7445f295eb4d0305ff455c3 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.63e-03 | 149 | 23 | 2 | 649eb3441fa859591ea85f1ed5fcf08af272a32b | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.70e-03 | 151 | 23 | 2 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-03 | 151 | 23 | 2 | 78475027bba9e3026e42493fec8ea630972353bb | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-03 | 152 | 23 | 2 | 82a493ffb2f1704cd6f68a82d970fe12f537d20e | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.74e-03 | 152 | 23 | 2 | 072daae0deb6cb92f126e4566f1d264cda9ed157 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-03 | 153 | 23 | 2 | 9c3220604b7fa4d91577b6c46960960f49644ca1 | |
| ToppCell | droplet-Fat-SCAT-30m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-03 | 153 | 23 | 2 | 2731c3d4ac40ecc22108f8f3f45a069077159125 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-03 | 153 | 23 | 2 | ba624782693b0daa642e50881dbf5f0663fea82d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-03 | 154 | 23 | 2 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.85e-03 | 155 | 23 | 2 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | (03)_Secretory-(2)_48hpi|(03)_Secretory / shred by cell type and Timepoint | 2.85e-03 | 155 | 23 | 2 | d3b3d5764dfccaa4564f6063da7e13633a4f4b73 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 2.85e-03 | 155 | 23 | 2 | 83430a64c2cb5ad29caa3dacba76c28dd204ac40 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-03 | 156 | 23 | 2 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | Control-Endothelial-Epi-like-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-03 | 157 | 23 | 2 | 2c369660c752c0fb3bd798a561d3359e2f9aa983 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.92e-03 | 157 | 23 | 2 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-03 | 157 | 23 | 2 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | Control-Endothelial-Epi-like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-03 | 157 | 23 | 2 | 4d02c50d5d1b892ea241e98724386d8a5a156a46 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic-non-classical_monocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.95e-03 | 158 | 23 | 2 | be9d7410f152071e3af971bc09181818070228a0 | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 2.95e-03 | 158 | 23 | 2 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.95e-03 | 158 | 23 | 2 | 74aa4f75307575ac3b2b1aa9f727753692f88742 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-03 | 158 | 23 | 2 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-03 | 158 | 23 | 2 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-03 | 158 | 23 | 2 | ef5feb48161c339c7b71c576bdda61479d29dfac | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-03 | 158 | 23 | 2 | df614450e10629dc9115d7365397663e82f9e48f | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-03 | 158 | 23 | 2 | c6e64b9b3342e37d54baadae8fb7dfb5d246e4cf | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-03 | 158 | 23 | 2 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-03 | 159 | 23 | 2 | 3bab00f8fb7d9232538e50f83dd0fd70ddd16819 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-03 | 159 | 23 | 2 | 323cb4a2416d2e6bff0a3f225d2edeae9ab7dc76 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.99e-03 | 159 | 23 | 2 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-03 | 159 | 23 | 2 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-03 | 160 | 23 | 2 | 30b7f24e0c3ecfa618b4e31678e18c8a4405a8d7 | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-03 | 160 | 23 | 2 | bd5fa7959bfe81011b8d798535b73ea1eee008b3 | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.03e-03 | 160 | 23 | 2 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-03 | 160 | 23 | 2 | 5bec867def73fa8531f8dad611679f4b44f573bd | |
| Computational | Genes in the cancer module 236. | 2.38e-04 | 18 | 14 | 2 | MODULE_236 | |
| Drug | monatepil | 1.85e-08 | 29 | 23 | 4 | CID000060810 | |
| Drug | Y-27632 | 4.05e-06 | 444 | 23 | 6 | CID000005711 | |
| Drug | pitavastatin | 4.90e-06 | 114 | 23 | 4 | CID005282451 | |
| Drug | chloroquine | 8.73e-06 | 288 | 23 | 5 | CID000002719 | |
| Drug | ezetimibe | 1.34e-05 | 147 | 23 | 4 | CID000150311 | |
| Drug | 25-hydroxycholesterol | 1.87e-05 | 160 | 23 | 4 | CID000065094 | |
| Drug | probucol | 1.97e-05 | 162 | 23 | 4 | CID000004912 | |
| Drug | epicholesterol | 3.12e-05 | 636 | 23 | 6 | CID000000304 | |
| Drug | coprogen | 3.50e-05 | 9 | 23 | 2 | CID006323272 | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.53e-05 | 188 | 23 | 4 | 4835_DN | |
| Drug | LMWH | 3.94e-05 | 663 | 23 | 6 | CID000000772 | |
| Drug | 25-azacoprostane | 4.37e-05 | 10 | 23 | 2 | CID000162243 | |
| Drug | Methiazole; Up 200; 15uM; MCF7; HT_HG-U133A | 4.40e-05 | 199 | 23 | 4 | 3878_UP | |
| Drug | P-Nz | 6.40e-05 | 12 | 23 | 2 | CID000029146 | |
| Drug | fenoxycarb | 7.03e-05 | 80 | 23 | 3 | CID000051605 | |
| Drug | AC1L1J6H | 8.53e-05 | 236 | 23 | 4 | CID000004889 | |
| Drug | pifarnine | 1.48e-04 | 18 | 23 | 2 | CID006436032 | |
| Drug | dhpta | 1.53e-04 | 104 | 23 | 3 | CID000018465 | |
| Drug | Calpain inhibitor I | 1.65e-04 | 280 | 23 | 4 | CID000004332 | |
| Drug | AC1L9732 | 2.01e-04 | 114 | 23 | 3 | CID000439300 | |
| Drug | clioquinol | 2.01e-04 | 114 | 23 | 3 | CID000002788 | |
| Disease | 3-carboxy-4-methyl-5-propyl-2-furanpropanoate CMPF measurement | 4.51e-05 | 13 | 23 | 2 | EFO_0021053 | |
| Disease | opioid use disorder | 6.56e-05 | 101 | 23 | 3 | EFO_0010702 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.45e-04 | 132 | 23 | 3 | DOID:10652 (is_implicated_in) | |
| Disease | systemic lupus erythematosus (is_marker_for) | 6.15e-04 | 47 | 23 | 2 | DOID:9074 (is_marker_for) | |
| Disease | Abdominal Aortic Aneurysm | 1.28e-03 | 68 | 23 | 2 | EFO_0004214 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSEACRENCEMPDWE | 276 | Q8TC20 | |
| CSALGCRQWDSDEME | 216 | Q9NZJ5 | |
| GCDGRMDSQQVWDRC | 531 | Q76LX8 | |
| MDSLDRSCQDWCDRK | 1 | Q5VTT2 | |
| DMWRDCTDGSDDNCS | 441 | Q9BY79 | |
| IPLRWRCDADADCMD | 3626 | Q07954 | |
| DNGADDWRIAMTCER | 171 | Q92952 | |
| EECLRCEWMDLNDLA | 241 | P53370 | |
| WMCSRCSANALEEDC | 761 | O75164 | |
| RAWLCDRDNDCGDMS | 1286 | P98164 | |
| SCGKTCREDRDDEWM | 111 | Q13797 | |
| CREDRDDEWMGVSLA | 116 | Q13797 | |
| RDSDGMDEQCRWCAE | 211 | P46100 | |
| LGDEAFDCDWDEEMR | 1126 | Q9NXL9 | |
| WCDFDNDCGDMSDER | 1096 | Q92673 | |
| IRSSWVCDGDNDCRD | 1171 | Q92673 | |
| RCSDWASAVEEDEMR | 71 | Q14493 | |
| QMWNREGCRCDEEPG | 271 | Q96MH2 | |
| RRISEHDQCEWRCMD | 341 | A8MXQ7 | |
| WDMRDSAVVCRELGC | 496 | A1L4H1 | |
| DVAKRACMESDWCRD | 421 | Q5SXH7 | |
| CTCDIGDFRRWMDEH | 776 | Q9NR97 | |
| CEDGWMGAACDQRAC | 746 | Q6N022 | |
| CNMARDCRDWSDEPI | 296 | P01130 | |
| LCCTWREERMGEEGS | 6 | P53667 |